Preoperative Sepsis Timeline, Profile and Its Association With Recipient Outcome Following Live Donor Liver Transplant
1 other identifier
observational
500
1 country
1
Brief Summary
Preoperative sepsis timeline, profile and its association with recipient outcome following live donor liver transplant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2021
CompletedFirst Posted
Study publicly available on registry
November 5, 2021
CompletedStudy Start
First participant enrolled
November 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2022
CompletedJanuary 26, 2022
October 1, 2021
3 months
October 20, 2021
January 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation of timeline of sepsis with recipient outcome following Live donor liver transplant.
a. Post-operative sepsis b. In hospital mortality c. Hospital stay d. ICU stay e. Retransfer to ICU f. Days on ventilator g. Need for tracheostomy/re-intubation h Duration of inotropic support
30 days
Secondary Outcomes (1)
study the correlation between recipient liver capsular and peritoneal macrophage activity and preoperative sepsis timeline, profile as well as post operative recipient outcome.
30 days
Study Arms (1)
This is an observational study
This is an observational study
Interventions
Eligibility Criteria
Patients undergoing/ undergone live donor liver transplant at our institute
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, 110070, India
Biospecimen
Explant liver with be sent for assessment of the subcapsular layer in addition to routine Histo pathological examination (HPE). 20 ml of peritoneal fluid from the recipient will also be collected and processed for analysis of peritoneal macrophages. Samples will then be subjected to flow cytometry for assessment of: 1. Macrophage identification markers: Quantitative assessment . 2. Macrophage Activation markers: Qualitative/ Activation assessment. Density and functionality of both LCM and PM will then be co-related to both pre-LT sepsis timeline and profile as well as post operative recipient outcome . Identification of Macrophage populations using Flow Cytometry and Immunohistochemistry
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Viniyendra Pamecha, FEBS
Institute of Liver & Biliary Sciences
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 20, 2021
First Posted
November 5, 2021
Study Start
November 5, 2021
Primary Completion
February 1, 2022
Study Completion
April 1, 2022
Last Updated
January 26, 2022
Record last verified: 2021-10